Distributing Microparticles
A method of distributing microparticles is provided, the method comprising: providing a plurality of microparticles at an insertion site in a medium; applying ultrasound to the insertion site that generates gas bubbles by cavitation at cavitation nuclei located at the insertion site and drives movement of the gas bubbles such that the gas bubbles drive movement of the microparticles into a desired spatial distribution in the tumour. The method may be a method of treating a tumour, and the microparticles may comprise a radioisotope for treating the tumour. Microparticles for use in the treatment of a tumour by the method are also disclosed.
1 . A method of distributing microparticles, the method comprising:
providing a plurality of microparticles at an insertion site in a medium; and
applying ultrasound to the insertion site that generates gas bubbles by cavitation at cavitation nuclei located at the insertion site and drives movement of the gas bubbles such that the gas bubbles drive movement of the microparticles into a desired spatial distribution in the medium.
2 . The method of claim 1 , wherein the microparticles are microspheres.
3 . The method of claim 1 , wherein the microparticles of the plurality of microparticles have an average size of 200 μm or less and/or wherein the microparticles of the plurality of microparticles have an average size of 1 μm or more.
4 . (canceled)
5 . The method of claim 1 , wherein the microparticles of the plurality of microparticles have a density of 10 g/ml or less and/or wherein the microparticles of the plurality of microparticles have a density of 1 g/ml or more.
6 . (canceled)
7 . The method of claim 1 , wherein the microparticles comprise a ceramic.
8 . The method of claim 1 , wherein the microparticles comprise at least one radioisotope.
9 . The method of claim 8 , wherein the radioisotope is a beta- or gamma-emitting radioisotope.
10 . The method of claim 9 , wherein the radioisotope is yttrium-90, iodine-125, copper-64, scandium-44, leutitium-176, or holmium-166.
11 . The method of claim 10 , wherein the microparticles comprise a yttrium aluminosilicate glass.
12 . The method of claim 8 , wherein the microparticles emit radiation with an activity of 10 Bq or more and/or where the microparticles emit radiation with an activity of 5000 Bq or less.
13 . (canceled)
14 . The method of claim 1 , wherein the cavitation nuclei are exogenous to the medium, and wherein the method further comprises providing a plurality of cavitation nuclei at the insertion site.
15 . The method of claim 14 , wherein a composition comprising the plurality of microparticles and the plurality of cavitation nuclei is provided at the insertion site.
16 . The method of claim 14 , wherein the plurality of microparticles and the plurality of cavitation nuclei are provided at the insertion site in separate steps.
17 . The method of claim 1 , wherein the cavitation nuclei are endogenous to the medium.
18 . The method of claim 1 , wherein the cavitation nuclei comprise at least one of: microbubbles, nanobubbles, nanodroplets and gas stabilising nanoparticles.
19 . The method of claim 1 , wherein the ultrasound has a fundamental frequency of in the range from 0.1 to 5 MHz, and/or wherein the ultrasound has a pulse repetition frequency of in the range from 0.1 to 10 Hz, and/or wherein the ultrasound has a duty cycle of in the range from 1% to 100%, and/or wherein the ultrasound exerts a peak pressure in the range from 1 to 20 MPa at the insertion site.
20 - 22 . (canceled)
23 . The method of claim 1 , wherein the medium is a tissue of a patient.
24 . The method of claim 23 , wherein the method is a method of treating a tumour in the patient, the plurality of microparticles comprise at least one radioisotope, and the spatial distribution is for providing radiation to treat the tumour, each microparticle comprising a radioisotope.
25 . The method of claim 24 , wherein the insertion site is within the tumour or wherein the insertion site is adjacent to the tumour.
26 - 28 . (canceled)
29 . The method of claim 24 , wherein the tumour is a solid tumour.
30 - 40 . (canceled)